Status unknownNCT01701830Updated Oct 5, 2012

Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease

An observational study in Non-diabetic Chronic Kidney Disease and Atherosclerosis, sponsored by Kocaeli Derince Education and Research Hospital. Status unknown at 1 site in Turkey. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-10-05.

Sponsored by Kocaeli Derince Education and Research Hospital · Observational

The sponsor has not verified this record recently (last verified Oct 2012), so the status shown — last known as Recruiting — may be out of date.

Study type: Observational
Model: Case-control
Time perspective: Cross-sectional
Enrollment: 85
Ages: 18 Years to 75 Years
Sex: All

Study summary

The aim of the study is to evaluate whether a low level of serum omentin-1 is associated with carotid atherosclerosis and mediated by inflammation.

Read the detailed description

Atherosclerotic cardiovascular disease is markedly increased in chronic kidney disease. There are a lot of risk factor, along with conventional risk factors. Serum onemtin-1 is a adipokine and suggested as a new marker for vascular disease.It has some anti-atherogenic properties. Studies investigating serum omentin-1 level have usually conducted in patients with diabetes mellitus.

Conditions studied

Non-diabetic Chronic Kidney Disease
Atherosclerosis

Browse trials for

Keywords

omentin-1
carotid atherosclerosis
kidney disease

In context

Carotid Artery Diseases

248 studies on the registry are indexed under Carotid Artery Diseases; 56 are open to participants now.

This study's planned enrollment of 85 is below the median of 224 across 108 observational studies indexed under Carotid Artery Diseases.

Browse Carotid Artery Diseases studies →

Lead sponsor

Kocaeli Derince Education and Research Hospital is the lead sponsor of 28 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years to 75 Years
Sexes eligible: All
Accepts healthy volunteers: Yes
Sampling method: Non-probability sample

Study population

Department of Nephrology, Check-up clinic

Inclusion criteria

between ages of 18 - 65 years old chronic kidney disease of stage 3-4

Exclusion criteria

Exclusion Criteria:

Chronic kidney disease of stage 5
The history of ischemic cardiovascular disease (myocardial infarction, unstable angina, stroke, peripheral artery disease, or cardiovascular revascularization)
Severe heart failure
Stage 2 hypertension
Diabetes mellitus
Corticosteroid therapy
Severe hepatic disease
Smoking
Inflammatory disease
Acute infectious disease
Malignancy

Study design

Observational model: Case-control
Time perspective: Cross-sectional
Enrollment: 85 participants (estimated)

Groups and cohorts

Case Group
Patients with chronic kidney disease of stage 3-4.
Control group
30 healthy subject

Study locations

1 of 1 sites recruiting

Department of Nephrology, Check-up Clinic,Kocaeli Derince Education and Traning Hospital
Izmit, Kocaeli 41100, Turkey
- Rabia TERZI, MD · Contact · drrabia1@yahoo.com · 90262 317 80 00
- Erkan SENGUL, MD · Principal investigator
- Gokhan DUYGULU, MD · Sub investigator
- Sevim DINDAR, MD · Sub investigator
- Fatih BUNUL, MD · Sub investigator
Recruiting

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Oct 5, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT01701830
Lead sponsor: Kocaeli Derince Education and Research Hospital
Responsible party: Sponsor
First posted: Oct 5, 2012
Start date: Oct 2012
Completion: May 2013 (estimated)
Last update: Oct 5, 2012

Study contacts

Erkan SENGUL, MD

principal investigator · Kocaeli Derince Education and Training Hospital

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Carotid Artery Diseases→

Other studies from this sponsor

Kocaeli Derince Education and Research Hospital

Start the discussion